Please login to the form below
Oliver Dennis
This page shows the latest Oliver Dennis news and features for those working in and with pharma, biotech and healthcare.
Fishawack Health acquires digital marketing agency closerlook
The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings,” said Oliver Dennis, co-founder and chief executive officer of Fishawack Health.
Latest news
-
Fishawack Health acquires market access and HEOR consultancy PRMA Consulting
We’re delighted to welcome PRMA Consulting to our group – our third acquisition of 2021,” Oliver Dennis, Fishawack Health Co-founder, and CEO, said.
-
Fishawack Health adds The Hive Health Group to its network
We’re excited to add Hive Health to the group – a strategically led healthcare communications brand with outstanding expertise in patient engagement,” said Oliver Dennis (pictured right), co-founder and chief ... pool of scientific, strategic and
-
2e Creative joins Fishawack Group
We’re challenging the major agency networks by fostering a uniquely collaborative culture across our agency collective,” said Oliver Dennis, CEO, Fishawack.
-
Fishawack acquires Dudnyk
Fishawack has wanted to add an East-coast healthcare marketing agency of scale and is pleased to have found that partnership with Dudnyk,” explains Oliver Dennis, CEO of Fishawack Group of ... Fishawack is unlike traditional networks that make
-
Fishawack acquires Blue Latitude Health
Consultancy latest in string of strategic acquisitions for Fishawack. Back row from L-R: Dominic Miller, Fred Bassett, Oliver Dennis. ... This is the third acquisition for Fishawack in just over a year, and Oliver Dennis, chief executive officer of the
More from news
Approximately 1 fully matching, plus 19 partially matching documents found.
Latest appointments
-
Fishawack appoints Jenifer Kirkland as CFO
Kirkland succeeds Dominic Miller, who will assume the responsibilities of chief operations officer, working closely with the group’s chief executive officer Oliver Dennis on further agency acquisitions. ... Dennis said: “Jenifer’s experience and
-
New UK business unit head for Fishawack
Lyons' appointment ties in with the Fishawack Group's 'buy and build' strategy, said CEO Oliver Dennis.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Fishawack Health appoints new CEO, Jonathan Koch
The company was founded by Oliver Dennis and Dominic Miller in 2001 and over the last two decades has grown rapidly through organic strategies and the acquisition of 16 companies spanning ... Jon’s appointment follows the news that Oliver and Dominic
-
Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack
Oliver Dennis, Fishawack Health co-founder and CEO, said: “Traditionally, the healthcare sector has fallen behind when it comes to leveraging the power of innovative technologies and data to enhance commercial
-
Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting
We’re delighted to welcome PRMA Consulting to our group – our third acquisition of 2021,” Oliver Dennis, Fishawack Health Co-founder, and CEO, said.
-
Fishawack Health, a new breed of global commercialization partner, fit for a post pandemic world
Fishawack Health CEO Oliver Dennis said, “We are a new breed of commercialization partner and can help healthcare companies navigate what is a rugged landscape.
-
Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans
Oliver Dennis, Fishawack Health co-founder and CEO, said: “In partnering with Bridgepoint, we have made a step-change in our ambition.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- AstraZeneca and Innate Pharma to end study on immuno-oncology drug monalizumab
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- bluebird bio reveals plans to launch two gene therapies
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
